Effects of dietary iron overload on progression in chemical hepatocarcinogenesis

Liver

Volumn 19, Issue 4, 1999, Pages 326-334

  Stål, Per ^a   Wang, Gen Sheng ^a   Olsson, Jerker M ^a   Eriksson, Lennart C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Experimental hepatocarcinogenesis; Glutathione; Iron overload; Transferase; Ubiquinone 9

Indexed keywords

ALPHA TOCOPHEROL; CARBONYL IRON; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; UBIQUINONE;

ABDOMINAL MASS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SIZE; CELL PROLIFERATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IRON INTAKE; IRON OVERLOAD; LIVER CARCINOGENESIS; LIVER HISTOLOGY; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PARTIAL HEPATECTOMY; RAT; WEIGHT REDUCTION;

2-ACETYLAMINOFLUORENE; ANIMALS; APOPTOSIS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLNITROSAMINE; DISEASE PROGRESSION; GLUTATHIONE TRANSFERASE; HEMOCHROMATOSIS; IRON; IRON, DIETARY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; UBIQUINONE; VITAMIN E;

EID: 0344655600     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00057.x     Document Type: Article

References (35)

1. DEUGNIER Y M, LOREAL O, TURLIN B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102: 2050-9.
2. STÅL P, GLAUMANN H, HULTCRANTZ R. Liver cell damage and lysosomal iron storage in patients with idiopathic hemochromatosis. A light and electron microscopic study. J Hepatol 1990; 11: 172-80.
3. NIEDERAU C, FISCHER R, PURSCHEL A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
4. FARGION S, MANDELLI C, PIPERNO A, et al. Survival and prognostic factors in 212 Italian patients with genetic gemochromatosis. Hepatology 1992; 15: 655-9.
5. IMLAY J A, CHIN S M, LINN S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988; 240: 640-2.
6. LOEB L A, JAMES E A, WALTERSDORPH A M, KLEBANOFF S J. Mutagenesis by the autoxidation of iron with isolated DNA. Proc Natl Acad Sci USA 1988; 85: 3912-22.
7. STÅL P, HULTCRANTZ R, MÖLLER L, ERIKSSON L C. The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology 1995; 21: 521-8.
8. CARTHEW P, NOLAN B M, SMITH A G, EDWARDS R E. Iron promotes DEN initiated GST-P foci in rat liver. Carcinogenesis 1997; 18: 599-603.
9. FAUX S P, FRANCIS J E, SMITH A G, CHIPMAN J K. Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254. Carcinogenesis 1992; 13: 247-50.
10. SMITH A G, FRANCIS J E, CARTHEW P. Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/1010ScSn mice. Carcinogenesis 1990; 11: 437-44.
11. SMITH A G, CARTHEW P, CLOTHIER B, et al. Synergy of iron in the toxicity and carcinogenicity of polychlorinated biphenyls (PCBs) and related chemicals. Toxicol Lett 1995; 82-83: 945-50.
12. NILSSON H, ERIKSSON L C. Growth factor induced mitogenic effects and inositol phosphate responses in primary hepatocyte cultures from normal rat liver and rat liver nodules. Carcinogenesis 1994; 15: 1821-6.
13. HANN H W, STAHLHUT M W, HANN C L. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 1990; 11: 566-9.
14. IANCU T C, WARD R J, PETERS T J. Ultrastructural observations in the carbonyl iron-fed rat, an animal model for hemochromatosis. Virchours Arch B Cell Pathol Incl Mol Pathol 1987; 53: 208-17.
15. PARK C H, BACON B R, BRITTENHAM G M, TAVILL A S. Pathology of dietary carbonyl iron overload in rats. Lab Invest 1987; 57: 555-63.
16. SOLT D B, FARBER E. New principle for the analysis of chemical carcinogens. Nature 1976; 263: 702-3.
17. ERIKSSON L C, ANDERSSON G N. Membrane biochemistry and chemical hepatocarcinogenesis. Crit Rev Biochem Mol Biol 1992; 27: 1-55.
18. FARBER E, SARMA D S. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987; 56: 4-22.
19. SUN I L, TOOLE-SIMMS W, CRANE F L, et al. Reductiion of diferric transfeerin by SV40 transformed pineal cells stimulates Na+/H+ antiport activity. Biochim Biophys Acta 1988; 938: 17-23.
20. DENDA A, TANG Q, TSUJIUCHI T, et al. Effects of oxidative stress induced by redox-enzyme modulation on the progression stage of rat hepatocarcinogenesis. Carcinogenesis 1993; 14: 95-101.
21. ITO N, TSUDA H, TATEMATSU M, et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathone S-transferase placental form positive foci in rats: - an approch for a new medium-term biossay system. Carcinogenesis 1988; 9: 387-94.
22. WEIBEL E R, KISTLER G S, SCHERLE W F. Practical stereological methods for morphometric cytology. J Cell Biol 1966; 30: 23-38.
23. LOWRY O H, ROSEBROUGH N J, FARR A L, RANDALE R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
24. ÅBERG F, APPELKVIST E L, DALLNER G, ERNSTER L. Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys 1992; 295: 230-4.
25. STEVENS R G, GRAUBARD B I, MICOZZI M S, et al. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994; 56: 364-9.
26. DEUGNIER Y M, CHARALAMBOUS P, LE QUILLEUC D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-9.
27. KATO J, KOBUNE M, KOHGO Y, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest 1996; 98: 923-9.
28. THELANDER L, GRASLUND A, THELANDER M. Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: possible regulation mechanism. Biochem Biophys Res Commun 1983; 110: 859-65.
29. BACON B R, BRITTON R S. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 1990; 11: 127-37.
30. VACA C E, HARMS-RINGDAHL M. Interaction of lipid peroxidation products with nuclear macromolecules. Biochim Biophys Acta 1989; 1001: 35-43.
31. PASCALE R M, DE MIGLIO M R, MURONI M R, et al. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat. Hepatology 1998; 27: 452-61.
32. BANNISTER W H, FEDERICI G, HEALTH J K, BANNISTER J V. Antioxidant systems in tumour cells: the levels of antioxidant enzymes, ferritin, and total iron in a human hepatoma cell line. Free Radic Res Commun 1986; 1: 361-7.
33. CHENOUFI N, LOREAL O, DRENOU B, et al. Iron may induce both DNA synthesis nad repair in rat hepatocytes stimulated by EGF/pyruvate. J Hepatol 1997; 26: 650-8.
34. ERNSTER L, FORSMARK P, NORDENBRAND K. The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. Biofactors 1992; 3: 241-8.
35. DABBAGH A J, MANNION T, LYNCH S M, FREI B. The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem J 1994; 300: 799-803.